Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar - - - -
Growth matrix (%)        
Revenue growth -- -- -- --
Op profit growth -- -- -- --
EBIT growth -- -- -- --
Net profit growth -- -- -- --
Profitability ratios (%)        
OPM -- -- -- --
EBIT margin -- -- -- --
Net profit margin -- -- -- --
RoCE -- -- -- --
RoNW -- -- -- --
RoA -- -- -- --
Per share ratios ()        
EPS -- -- -- --
Dividend per share -- -- -- --
Cash EPS -- -- -- --
Book value per share -- -- -- --
Valuation ratios        
P/E -- -- -- --
P/CEPS -- -- -- --
P/B -- -- -- --
EV/EBIDTA -- -- -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout -- -- -- --
Liquidity ratios        
Debtor days -- -- -- --
Inventory days -- -- -- --
Creditor days -- -- -- --
Leverage ratios        
Interest coverage -- -- -- --
Net debt / equity -- -- -- --
Net debt / op. profit -- -- -- --
Cost breakup ()        
Material costs -- -- -- --
Employee costs -- -- -- --
Other costs -- -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) - - - -
Revenue -- -- -- --
yoy growth (%) -- -- -- --
Raw materials -- -- -- --
As % of sales -- -- -- --
Employee costs -- -- -- --
As % of sales -- -- -- --
Other costs -- -- -- --
As % of sales -- -- -- --
Operating profit -- -- -- --
OPM -- -- -- --
Depreciation -- -- -- --
Interest expense -- -- -- --
Other income -- -- -- --
Profit before tax -- -- -- --
Taxes -- -- -- --
Tax rate -- -- -- --
Minorities and other -- -- -- --
Adj. profit -- -- -- --
Exceptional items -- -- -- --
Net profit -- -- -- --
yoy growth (%) -- -- -- --
NPM -- -- -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) - - - -
Profit before tax -- -- -- --
Depreciation -- -- -- --
Tax paid -- -- -- --
Working capital -- -- -- --
Other operating items -- -- -- --
Operating cashflow -- -- -- --
Capital expenditure -- -- -- --
Free cash flow -- -- -- --
Equity raised -- -- -- --
Investments -- -- -- --
Debt financing/disposal -- -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash -- -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2019 Mar-2018 - -
Equity capital 8.65 8.65 -- --
Preference capital -- -- -- --
Reserves 32.30 24.20 -- --
Net worth 40.90 32.90 -- --
Minority interest
Debt 20 7.50 -- --
Deferred tax liabilities (net) 0.15 0.15 -- --
Total liabilities 61 40.50 -- --
Fixed assets 32.40 14.50 -- --
Intangible assets
Investments 0.35 -- -- --
Deferred tax asset (net) 0.29 -- -- --
Net working capital 24.70 14.10 -- --
Inventories 9.53 2.80 -- --
Inventory Days -- -- -- --
Sundry debtors 25 14.40 -- --
Debtor days -- -- -- --
Other current assets 11.80 5.89 -- --
Sundry creditors (16) (6.10) -- --
Creditor days -- -- -- --
Other current liabilities (6.10) (3) -- --
Cash 3.30 11.90 -- --
Total assets 61 40.50 -- --
Switch to
Consolidated
Standalone


Beta Drugs Ltd Report not showing data